Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PAZOPANIB vs PEGASPARGASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PAZOPANIB vs PEGASPARGASE: Safety Overview

Metric PAZOPANIB PEGASPARGASE
Total FAERS Reports 21,208 11,543
Deaths Reported 5,612 1,555
Death Rate 26.5% 13.5%
Hospitalizations 4,347 6,990
Average Patient Age 61.2 yrs 15.4 yrs
% Female Patients 41.2% 42.8%
FDA Approval Date Apr 23, 2024 N/A
Manufacturer Golden State Medical Supply, Inc. Servier Pharmaceuticals LLC
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription